1137OInterim analysis of the phase 3 ADAPT trial evaluating...

Annals of Oncology 2017 / 09 Vol. 28; Iss. suppl_5

1137OInterim analysis of the phase 3 ADAPT trial evaluating rocapuldencel-T (AGS-003), an individualized immunotherapy for the treatment of newly-diagnosed patients with metastatic renal cell carcinoma (mRCC)

Figlin, R., Nicolette, C., Tannir, N., Tykodi, S.S., Chen, D., Master, V., Lane, B., Debenedette, M., Monesmith, T., Tan, W., Leland, S., Wood, C.G.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx376.003
Date:
September, 2017
File:
PDF, 50 KB
english, 2017
Conversion to is in progress
Conversion to is failed